Cellyan Biotechnology Co., Ltd (HKPD) stock
HKPDNasdaqWholesale-Drugs, Proprietaries & Druggists' SundriesFiscal year ends March 31
$1.33−0.19 (-12.76%)
Close on Nov 18, 2026Market cap $21.75MP/E –Yield –
Cellyan Biotechnology revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2026 it was $13.43M, down 33.9% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $13.43M | -33.9% |
| FY2025 | Mar 31, 2025 | $20.31M | +21.7% |
| FY2024 | Mar 31, 2024 | $16.69M | +32.9% |
| FY2023 | Mar 31, 2023 | $12.56M | – |
See a number that looks wrong?